Thomas F. Isett - 23 Sep 2021 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
CEO and Executive Chairman, Director
Signature
/s/Thomas F. Isett
Issuer symbol
IBIO
Transactions as of
23 Sep 2021
Net transactions value
$0
Form type
4
Filing time
27 Sep 2021, 17:30:39 UTC
Previous filing
13 Dec 2021
Next filing
12 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +2,000,000 $0.000000 2,000,000 23 Sep 2021 Common Stock 2,000,000 $1.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: (1) 25% of options granted will vest one year following the grant date; and (2) after one year following the grant date, 6.25% of the options granted will vest for each additional three (3) months of employment, subject to the conditions of the iBio, Inc. 2020 Omnibus Incentive Plan, as amended and the stock option grant agreement.